The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus–related hepatocellular carcinoma-Reference-Cited by-同舟云学术

The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus–related hepatocellular carcinoma

Published:2021-07 Issue: Volume:89 Page:48-55
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Lee Ji Hyun,Kim Beom Kyung,Park Soo Young,Tak Won Young^ORCID,Park Jun Yong,Kim Do Young,Ahn Sang Hoon,Sinn Dong Hyun,Kim Seung Up^ORCID

Funder

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

Publisher

Elsevier BV

Subject

Internal Medicine

Reference32 articles.

1. Unmet need in chronic hepatitis B management;Liang;Clin Mol Hepatol,2019

2. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

3. Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase;Lee;Clin Transl Gastroenterol,2020

4. Epidemiology of liver cancer in South Korea;Kim;Clin Mol Hepatol,2018

5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma;J Hepatol,2018

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timing of antiviral therapy in patients with hepatitis B virus related hepatocellular carcinoma undergoing hepatectomy;World Journal of Clinical Oncology;2024-09-24

2. Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy;Journal of the Formosan Medical Association;2024-08

3. Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma;BMC Cancer;2024-03-04

4. Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial;Trials;2024-01-05

5. Enhanced prognosis of HCC patients undergoing radical treatments with tenofovir versus entecavir: A meta-analysis based on propensity score matching studies;Asian Journal of Surgery;2024-01